This is a table of named entities, their types, and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel. Please keep in mind that named-entity extraction is not as accurate as more generic parts-of-speech extraction. Unusual results will appear here.
entity | type | frequency |
---|---|---|
covid | DISEASE | 472 |
covid 19 | ORG | 234 |
cancer | DISEASE | 130 |
pangolins | TAXON | 115 |
hydroxychloroquine | CHEMICAL | 110 |
copd | ORG | 109 |
coronavirus | TAXON | 105 |
infection | DISEASE | 102 |
genv | GPE | 97 |
bias | CHEMICAL | 85 |
human | TAXON | 72 |
dementia | DISEASE | 69 |
virus | TAXON | 66 |
malaria | TAXON | 65 |
individuals | TAXON | 63 |
china | GPE | 62 |
ciprofloxacin | CHEMICAL | 52 |
sars | DISEASE | 52 |
viral | TAXON | 51 |
death | DISEASE | 44 |
tcm | ORG | 43 |
coronavirus | TAXON | 42 |
infections | DISEASE | 41 |
dmc | ORG | 38 |
coronavirus disease | DISEASE | 37 |
hydroxychloroquine | CHEMICAL | 36 |
clinicaltrials | ORG | 36 |
streptomycin | CHEMICAL | 34 |
pneumonia | DISEASE | 33 |
critically ill | DISEASE | 32 |
azithromycin | CHEMICAL | 32 |
korea | GPE | 32 |
deaths | DISEASE | 31 |
ci | ORG | 30 |
chloroquine | CHEMICAL | 30 |
lopinavir ritonavir | PERSON | 29 |
animal | TAXON | 29 |
us | GPE | 29 |
cov | CHEMICAL | 29 |
fda | ORG | 28 |
prednisone | CHEMICAL | 27 |
sars cov 2 | ORG | 27 |
meta | ORG | 27 |
mers | DISEASE | 26 |
ich | DISEASE | 26 |
dexamethasone | CHEMICAL | 26 |
wuhan | GPE | 26 |
ants | TAXON | 26 |
the united states | GPE | 25 |
humans | TAXON | 25 |
bubonic plague | ORG | 25 |
ipm | ORG | 25 |
iii | ORG | 25 |
cancer | DISEASE | 25 |
human | TAXON | 24 |
acute respiratory failure | DISEASE | 23 |
psoriasis | DISEASE | 23 |
breast cancer | DISEASE | 22 |
respiratory failure | DISEASE | 22 |
uk | GPE | 21 |
rct | ORG | 21 |
italy | GPE | 21 |
respiratory distress syndrome | DISEASE | 20 |
eu | ORG | 20 |
dementia | GPE | 20 |
apes | TAXON | 19 |
gcp | ORG | 19 |
infectious diseases | DISEASE | 19 |
curcumin | PERSON | 19 |
oxygen | CHEMICAL | 19 |
viruses | TAXON | 18 |
chimpanzees | TAXON | 18 |
europe | LOC | 18 |
azithromycin | CHEMICAL | 18 |
animals | TAXON | 17 |
cc | CHEMICAL | 17 |
crf | DISEASE | 17 |
chloroquine | CHEMICAL | 17 |
ii | ORG | 17 |
journal | ORG | 17 |
cognitive flexibility | DISEASE | 17 |
malarial | TAXON | 17 |
pain | DISEASE | 17 |
sepsis | DISEASE | 17 |
pe | ORG | 16 |
hemonc | ORG | 16 |
ali | ORG | 16 |
mice | TAXON | 16 |
septoplasty | GPE | 16 |
inflammation | DISEASE | 15 |
fever | DISEASE | 15 |
bivalirudin | PERSON | 15 |
pangolins | CHEMICAL | 15 |
ac | ORG | 15 |
remdesivir | PERSON | 14 |
be | GPE | 14 |
irb | ORG | 14 |
norway | GPE | 14 |
rdt | ORG | 14 |
tnf | ORG | 14 |
snot | ORG | 14 |
bronchiolitis | DISEASE | 14 |
cannabis | ORG | 14 |
nonhuman primates | TAXON | 14 |
ra | ORG | 13 |
france | GPE | 13 |
miracle | ORG | 13 |
madagascar | GPE | 13 |
spain | GPE | 13 |
chronic obstructive pulmonary disease | DISEASE | 13 |
who | ORG | 13 |
nasal obstruction | DISEASE | 13 |
npr | ORG | 12 |
tumor | DISEASE | 12 |
stroke | DISEASE | 12 |
multicentre | PERSON | 12 |
heparin | CHEMICAL | 12 |
glucocorticoids | CHEMICAL | 12 |
tmg | ORG | 12 |
nih | ORG | 12 |
k | CHEMICAL | 12 |
it | CHEMICAL | 12 |
harriett | PERSON | 11 |
iqr | ORG | 11 |
mcar | ORG | 11 |
curcumin | PERSON | 11 |
jwby | ORG | 11 |
hiv | TAXON | 11 |
quercetin | PERSON | 11 |
depression | DISEASE | 11 |
vitamin c | CHEMICAL | 11 |
respiratory syndrome | DISEASE | 11 |
cholera | DISEASE | 11 |
sunda | ORG | 10 |
covid19 | ORG | 10 |
coronavirus disease | DISEASE | 10 |
gmo | ORG | 10 |
gtm | ORG | 10 |
hgr | ORG | 10 |
il | ORG | 10 |
imp | ORG | 10 |
mmf | ORG | 10 |
middle east | LOC | 10 |
daris | ORG | 10 |
trials | ORG | 10 |
apremilast | CHEMICAL | 10 |
colorectal cancer | DISEASE | 10 |
infectious disease | DISEASE | 10 |
malarial drug | TAXON | 10 |
methotrexate | CHEMICAL | 10 |
outbreaks | TAXON | 10 |
quercetin | CHEMICAL | 10 |
resveratrol | CHEMICAL | 10 |
the world health organization | ORG | 10 |
toxicity | DISEASE | 10 |
ards | GPE | 9 |
coronavirus disease | DISEASE | 9 |
phase | ORG | 9 |
sap | ORG | 9 |
acute lung injury | DISEASE | 9 |
acute respiratory syndrome coronavirus 2 sars cov | DISEASE | 9 |
cancers | DISEASE | 9 |
complexity | DISEASE | 9 |
elephants | TAXON | 9 |
plaque psoriasis | DISEASE | 9 |
mar | ORG | 8 |
appendix | GPE | 8 |
belmont | GPE | 8 |
cd20 | ORG | 8 |
ciprofloxacin | ORG | 8 |
ec | ORG | 8 |
ema | ORG | 8 |
ictrp | ORG | 8 |
itt | ORG | 8 |
jacobson hopper 2019 | ORG | 8 |
kcdc | ORG | 8 |
azathioprine | CHEMICAL | 8 |
nairos | ORG | 8 |
inferiority | DISEASE | 8 |
pvc | ORG | 8 |
rheumatoid arthritis | DISEASE | 8 |
lung cancer | DISEASE | 8 |
respiratory disease | DISEASE | 8 |
failure | DISEASE | 8 |
viral infections | DISEASE | 8 |
victoria | GPE | 8 |
toc | ORG | 8 |
pes | CHEMICAL | 7 |
salk | ORG | 7 |
recovery | ORG | 7 |
qri | ORG | 7 |
pangolins science society | ORG | 7 |
pain | DISEASE | 7 |
pnif | ORG | 7 |
live | ORG | 7 |
nsclc | ORG | 7 |
nhs | ORG | 7 |
n95 | ORG | 7 |
mfds | CHEMICAL | 7 |
acute respiratory distress syndrome | DISEASE | 7 |
dsmb | ORG | 7 |
animal | TAXON | 7 |
schmitz | PERSON | 7 |
streptomycin | LOC | 7 |
the ards network | ORG | 7 |
iphone | ORG | 7 |
tocilizumab | CHEMICAL | 7 |
the us food and drug administration | ORG | 7 |
al 2016 | PERSON | 7 |
thalidomide | CHEMICAL | 7 |
sulfadoxine pyrimethamine | CHEMICAL | 7 |
prostate cancer | DISEASE | 7 |
imatinib | CHEMICAL | 7 |
gorillas | TAXON | 7 |
gaps | DISEASE | 7 |
favipiravir | CHEMICAL | 7 |
cyclosporine | CHEMICAL | 7 |
cisplatin | CHEMICAL | 7 |
bleeding | DISEASE | 7 |
aneurysm | DISEASE | 7 |
rrr | ORG | 6 |
asthma | DISEASE | 6 |
anxiety | DISEASE | 6 |
united states | GPE | 6 |
tsc | ORG | 6 |
cannabidiol | CHEMICAL | 6 |
nose | ORG | 6 |
healthcare | ORG | 6 |
csm | ORG | 6 |
bivalirudin | PERSON | 6 |
australia | GPE | 6 |
bubo | TAXON | 6 |
ribavirin | CHEMICAL | 6 |
chloroquine diphosphate | CHEMICAL | 6 |
cough | DISEASE | 6 |
gentamicin | CHEMICAL | 6 |
intussusception | DISEASE | 6 |
macrolide | CHEMICAL | 6 |
mycophenolate mofetil | CHEMICAL | 6 |
ncov | ORG | 6 |
plague | GPE | 6 |
steroid | CHEMICAL | 6 |
tumor necrosis | DISEASE | 6 |
coronavirus pneumonia | DISEASE | 6 |
favipiravir | PERSON | 5 |
ebola virus disease | DISEASE | 5 |
england | GPE | 5 |
ethics | ORG | 5 |
hib | ORG | 5 |
ferneley | PERSON | 5 |
guinea | TAXON | 5 |
herein | ORG | 5 |
distrust | GPE | 5 |
igg | ORG | 5 |
ecg | ORG | 5 |
california | GPE | 5 |
diabetes | DISEASE | 5 |
d21 | PERSON | 5 |
d11 | PERSON | 5 |
challenges | ORG | 5 |
copd exacerbations | DISEASE | 5 |
blood | ORG | 5 |
africa | LOC | 5 |
ali acute lung injury ards acute respiratory distress syndrome | DISEASE | 5 |
ad | DISEASE | 5 |
acc | ORG | 5 |
lancet | ORG | 5 |
infection | DISEASE | 5 |
peter | PERSON | 5 |
lopinavir ritonavir | CHEMICAL | 5 |
bovine | TAXON | 5 |
tyrosine | CHEMICAL | 5 |
tumors | DISEASE | 5 |
statins | CHEMICAL | 5 |
melanoma | DISEASE | 5 |
influenza infection | DISEASE | 5 |
head and neck cancer | DISEASE | 5 |
gastrointestinal bleeding | DISEASE | 5 |
disorder | DISEASE | 5 |
comorbidity | DISEASE | 5 |
colchicine | CHEMICAL | 5 |
glucose | CHEMICAL | 5 |
yersinia | TAXON | 5 |
off | CHEMICAL | 5 |
thatcher | PERSON | 5 |
nasal | PERSON | 5 |
netherlands | GPE | 5 |
orchid | ORG | 5 |
mers cov infection | ORG | 5 |
pis | ORG | 5 |
pwd | ORG | 5 |
pagerank | ORG | 5 |
sun | ORG | 5 |
na k | LOC | 4 |
koopman | TAXON | 4 |
li | CHEMICAL | 4 |
mtx | ORG | 4 |
medline | ORG | 4 |
mice | TAXON | 4 |
michael | PERSON | 4 |
mometasone | TAXON | 4 |
nct | CHEMICAL | 4 |
nctu | ORG | 4 |
jia wei | PERSON | 4 |
sars cov | ORG | 4 |
new zealand | GPE | 4 |
omalizumab | ORG | 4 |
oseltamivir | ORG | 4 |
pd | DISEASE | 4 |
pi | ORG | 4 |
pp | CHEMICAL | 4 |
phase iii | PERSON | 4 |
results | PERSON | 4 |
russ | PERSON | 4 |
sae | ORG | 4 |
iran | GPE | 4 |
jens ulrik | PERSON | 4 |
doass | ORG | 4 |
influenza | ORG | 4 |
india | GPE | 4 |
selective | ORG | 4 |
ar | ORG | 4 |
ahuja | GPE | 4 |
alzheimer s disease | DISEASE | 4 |
americas | TAXON | 4 |
bsh | ORG | 4 |
cop | CHEMICAL | 4 |
cta | ORG | 4 |
chloroquine phosphate | CHEMICAL | 4 |
ciborra | DISEASE | 4 |
control | ORG | 4 |
creative commons | ORG | 4 |
determine | ORG | 4 |
determines | PERSON | 4 |
ev | ORG | 4 |
ebola virus | TAXON | 4 |
epidemiological | ORG | 4 |
gautret | PERSON | 4 |
hiv infected | DISEASE | 4 |
ice | ORG | 4 |
itti | ORG | 4 |
sdd | ORG | 4 |
analysis | PERSON | 4 |
septoplasty | PERSON | 4 |
respiratory syndrome coronavirus | DISEASE | 4 |
exacerbations of chronic obstructive pulmonary disease | DISEASE | 4 |
fish | TAXON | 4 |
glioblastoma | DISEASE | 4 |
interferon | ORG | 4 |
interferon alpha 2b | CHEMICAL | 4 |
lactate | CHEMICAL | 4 |
lupus erythematosus | DISEASE | 4 |
mefloquine | CHEMICAL | 4 |
methylprednisolone | CHEMICAL | 4 |
respiratory diseases | DISEASE | 4 |
respiratory syndrome coronavirus 2 sars | DISEASE | 4 |
doxycycline | CHEMICAL | 4 |
septic shock | DISEASE | 4 |
sprays | CHEMICAL | 4 |
steroids | CHEMICAL | 4 |
syncytial virus | TAXON | 4 |
shanghai | GPE | 4 |
thrombocytopenia | GPE | 4 |
tuberculosis | DISEASE | 4 |
turbinate reduction | DISEASE | 4 |
viral infection | DISEASE | 4 |
vitamin d | CHEMICAL | 4 |
exacerbations | DISEASE | 4 |
the united kingdom | GPE | 4 |
doxorubicin | CHEMICAL | 4 |
acute ischemic stroke | DISEASE | 4 |
dihydroartemisinin piperaquine | CHEMICAL | 4 |
sobreperez | PERSON | 4 |
solidarity | ORG | 4 |
south | LOC | 4 |
sponsors | ORG | 4 |
tnfalpha | ORG | 4 |
tpp | PERSON | 4 |
time | ORG | 4 |
ulrik | DISEASE | 4 |
world health organization | ORG | 4 |
southeast asia | LOC | 4 |
acute respiratory syndrome | DISEASE | 4 |
cognitive impairment | DISEASE | 4 |
alopecia areata | PERSON | 4 |
crizotinib | CHEMICAL | 4 |
coronavirus covid | DISEASE | 4 |
colon cancer | DISEASE | 4 |
conflict | DISEASE | 4 |
captive | TAXON | 4 |
bubonic | DISEASE | 4 |
atopic dermatitis | DISEASE | 4 |
dengue | DISEASE | 4 |
mobid | ORG | 3 |
midi | ORG | 3 |
kjr | ORG | 3 |
lopinavir ritonavir | CHEMICAL | 3 |
london | GPE | 3 |
loeb | GPE | 3 |
lack | PERSON | 3 |
lmst | ORG | 3 |
imi | ORG | 3 |
josefin | ORG | 3 |
jacobson hopper | PERSON | 3 |
jacobson | PERSON | 3 |
inclusion | GPE | 3 |
ili | ORG | 3 |
id | DISEASE | 3 |
med doi | PERSON | 3 |
ich gcp | ORG | 3 |
manis | PERSON | 3 |
pubmed | PERSON | 3 |
mouse | TAXON | 3 |
psoriasis | DISEASE | 3 |
hopper | GPE | 3 |
resveratrol | PERSON | 3 |
respiratory syndrome coronavirus 2 sars | DISEASE | 3 |
respiratory syndrome | DISEASE | 3 |
respiratory distress syndrome | DISEASE | 3 |
rud | ORG | 3 |
reduce | ORG | 3 |
prone | CHEMICAL | 3 |
north america | LOC | 3 |
pradeesh sivapalan | PERSON | 3 |
pluto | PERSON | 3 |
pangolin | CHEMICAL | 3 |
ppe | ORG | 3 |
php | ORG | 3 |
peep | ORG | 3 |
orr | ORG | 3 |
huang qin | PERSON | 3 |
community | ORG | 3 |
hib disease | DISEASE | 3 |
canada | GPE | 3 |
cosaque | GPE | 3 |
coronavirus covid | DISEASE | 3 |
sas | ORG | 3 |
chronic obstructive pulmonary disease | DISEASE | 3 |
chemotherapy | PERSON | 3 |
central | LOC | 3 |
carroll | ORG | 3 |
cvd | ORG | 3 |
cox | PERSON | 3 |
ctcae | ORG | 3 |
bushen yiqi | PERSON | 3 |
bergen baerum | PERSON | 3 |
bergen | ORG | 3 |
b23 | ORG | 3 |
asia | LOC | 3 |
acp | ORG | 3 |
covid 19 | PERSON | 3 |
cyclosporine | ORG | 3 |
hra | CHEMICAL | 3 |
ebola | TAXON | 3 |
h1n1 | GPE | 3 |
generation victoria genv | PERSON | 3 |
garry | PERSON | 3 |
fio | CHEMICAL | 3 |
epidemic | DISEASE | 3 |
elephants | TAXON | 3 |
efficacy | ORG | 3 |
een | ORG | 3 |
d11 proportion of | ORG | 3 |
did | CHEMICAL | 3 |
dexamethasone | CHEMICAL | 3 |
depression | DISEASE | 3 |
denmark | GPE | 3 |
davis | PERSON | 3 |
data monitoring committee | ORG | 3 |
dress | ORG | 3 |
rubin | PERSON | 3 |
japan | GPE | 3 |
siv | ORG | 3 |
diseases | DISEASE | 3 |
organisms | TAXON | 3 |
neuropsychiatric symptoms | DISEASE | 3 |
neoplasms | DISEASE | 3 |
nasopharyngitis | GPE | 3 |
mouse | TAXON | 3 |
mometasone furoate | CHEMICAL | 3 |
mometasone | CHEMICAL | 3 |
metastasis | DISEASE | 3 |
interferon | ORG | 3 |
infectious | DISEASE | 3 |
indacaterol | CHEMICAL | 3 |
ipad | LOC | 3 |
hypoxia | DISEASE | 3 |
hypertension | DISEASE | 3 |
hydroxychloroquine chloroquine | CHEMICAL | 3 |
heart failure | DISEASE | 3 |
gain | DISEASE | 3 |
ovarian cancer | DISEASE | 3 |
pangolin | GPE | 3 |
pipeline | CHEMICAL | 3 |
the relative stress scale | ORG | 3 |
solidarity | ORG | 3 |
vomiting | DISEASE | 3 |
urticaria | DISEASE | 3 |
the university of oxford | ORG | 3 |
the university of chicago | ORG | 3 |
the university of bergen | ORG | 3 |
the research council | ORG | 3 |
the medical research council | ORG | 3 |
prednisolone | CHEMICAL | 3 |
the european medicines agency ema | ORG | 3 |
the european medicines agency | ORG | 3 |
streptomycin ciprofloxacin | CHEMICAL | 3 |
sildenafil | CHEMICAL | 3 |
respiratory distress | DISEASE | 3 |
psychosis | DISEASE | 3 |
psychiatric | DISEASE | 3 |
docetaxel | CHEMICAL | 3 |
retroviral | TAXON | 3 |
diabetes | DISEASE | 3 |
springer nature | ORG | 3 |
virus | TAXON | 3 |
vietnam | GPE | 3 |
vaccines | ORG | 3 |
vn | GPE | 3 |
vek | ORG | 3 |
systematic | LOC | 3 |
surfactant | PERSON | 3 |
sierra leone | ORG | 3 |
wales | GPE | 3 |
sequential | ORG | 3 |
sepsis | DISEASE | 3 |
seoul | GPE | 3 |
secukinumab | TAXON | 3 |
sabin | PERSON | 3 |
depressive | DISEASE | 3 |
ssg | ORG | 3 |
wmd | ORG | 3 |
shirahada | GPE | 3 |
zika | PERSON | 3 |
chronic idiopathic urticaria | DISEASE | 3 |
creatinine urea | CHEMICAL | 3 |
curcumin quercetin | PERSON | 3 |
acute respiratory syndrome coronavirus 2 | DISEASE | 3 |
cortisol | CHEMICAL | 3 |
coronavirus infection | DISEASE | 3 |
contagion | DISEASE | 3 |
chronic rhinosinusitis | DISEASE | 3 |
confusion | DISEASE | 3 |
chimpanzees pan troglodytes | TAXON | 3 |
cerebral aneurysms | DISEASE | 3 |
al 2019 | PERSON | 3 |
bacterial | TAXON | 3 |
atopic eczema | DISEASE | 3 |
aminoglycosides | CHEMICAL | 3 |
arboreal | TAXON | 3 |
mh | ORG | 2 |
malawi | PERSON | 2 |
malaria | DISEASE | 2 |
mrc | ORG | 2 |
mds | DISEASE | 2 |
mers infection | DISEASE | 2 |
lynch | DISEASE | 2 |
mda | CHEMICAL | 2 |
luminex | PERSON | 2 |
medical | ORG | 2 |
macro | ORG | 2 |
marco | CHEMICAL | 2 |
mycophenolate | PERSON | 2 |
mediterranean | LOC | 2 |
michael b99 | PERSON | 2 |
models | ORG | 2 |
monographs | PERSON | 2 |
morrison | ORG | 2 |
multi | GPE | 2 |
n y c | ORG | 2 |
np | ORG | 2 |
naseptin bactroban | PERSON | 2 |
naseptin nasal cream | PERSON | 2 |
lingwen | CHEMICAL | 2 |
numbers | ORG | 2 |
nepotism | ORG | 2 |
lopinavir ritonavir remdesivir | PERSON | 2 |
jazz pharmaceuticals | ORG | 2 |
linear | ORG | 2 |
kras | ORG | 2 |
institutional review boards | ORG | 2 |
organizational | ORG | 2 |
interferon | ORG | 2 |
internal medicine journal | ORG | 2 |
interventions | GPE | 2 |
iranian registry of clinical trials irct | ORG | 2 |
j d d | PERSON | 2 |
jama | ORG | 2 |
jakarta | GPE | 2 |
jakobsen | PERSON | 2 |
journal | ORG | 2 |
kazembe | GPE | 2 |
lincocin | GPE | 2 |
kendall | PERSON | 2 |
kristiansand | GPE | 2 |
ldh | ORG | 2 |
lib | ORG | 2 |
loess | ORG | 2 |
lsg | ORG | 2 |
lastly | ORG | 2 |
le comité | CHEMICAL | 2 |
lessons | ORG | 2 |
leukemia | PERSON | 2 |
lifestyle | ORG | 2 |
ohio | GPE | 2 |
rossi | PERSON | 2 |
origins | PERSON | 2 |
oxford | ORG | 2 |
rs | DISEASE | 2 |
radix | PERSON | 2 |
regeneron | ORG | 2 |
remdesivir lopinavir ritonavir lopinavir ritonavir | PERSON | 2 |
research of mashhad university of medical sciences | ORG | 2 |
review | ORG | 2 |
risk | PERSON | 2 |
roman | PERSON | 2 |
roundup | CHEMICAL | 2 |
ruxolitinib | PERSON | 2 |
sabds | CHEMICAL | 2 |
sars cov | ORG | 2 |
sars coronavirus infection | DISEASE | 2 |
sd | DISEASE | 2 |
siopen | CHEMICAL | 2 |
scheiner | PERSON | 2 |
sj een jf | ORG | 2 |
smart | ORG | 2 |
snot 22 | ORG | 2 |
sp | CHEMICAL | 2 |
stata | ORG | 2 |
san simón | PERSON | 2 |
saudi arabia | GPE | 2 |
schapiro lambeth | PERSON | 2 |
initiation | ORG | 2 |
results | ORG | 2 |
reg | GPE | 2 |
qol | PERSON | 2 |
phase ii | PERSON | 2 |
pcr | ORG | 2 |
pdw | ORG | 2 |
pioneer | ORG | 2 |
pis | ORG | 2 |
pmd | ORG | 2 |
pps | ORG | 2 |
paclitaxel | ORG | 2 |
pan | ORG | 2 |
pan paniscus | ORG | 2 |
pediatric risk | PERSON | 2 |
percentages | ORG | 2 |
pierre | DISEASE | 2 |
qatar | GPE | 2 |
pinsonneault | ORG | 2 |
plague | GPE | 2 |
plotnik | GPE | 2 |
pongo | GPE | 2 |
porcine | TAXON | 2 |
practical | GPE | 2 |
prednisone | CHEMICAL | 2 |
presidenza | ORG | 2 |
provenance | PERSON | 2 |
psychometric | PERSON | 2 |
pubmed embase | PERSON | 2 |
innovative | ORG | 2 |
adaptive | ORG | 2 |
informed consent form | ORG | 2 |
contingency | ORG | 2 |
barki | ORG | 2 |
beaudry | GPE | 2 |
betty | PERSON | 2 |
bradford better start | ORG | 2 |
c1 c9 | ORG | 2 |
cat | ORG | 2 |
clsi | ORG | 2 |
cpl | ORG | 2 |
cpm | ORG | 2 |
cq | CHEMICAL | 2 |
csb | ORG | 2 |
ctc | ORG | 2 |
calendar | PERSON | 2 |
captive | TAXON | 2 |
chauvenet alienor | PERSON | 2 |
chi shao | PERSON | 2 |
chronic | ORG | 2 |
ciborra 1999 | PERSON | 2 |
ciborra 2002 | PERSON | 2 |
clark | PERSON | 2 |
clexane | ORG | 2 |
clin epidemiol | PERSON | 2 |
clinicaltrial | ORG | 2 |
cmax | CHEMICAL | 2 |
comparative | ORG | 2 |
bagayogo et al 2014 | PERSON | 2 |
bts | CHEMICAL | 2 |
braf | ORG | 2 |
agitation | DISEASE | 2 |
scotland england | LOC | 2 |
93ggxzxu | CHEMICAL | 2 |
aan | ORG | 2 |
adi | ORG | 2 |
apc | ORG | 2 |
aud | ORG | 2 |
acute | PERSON | 2 |
acute lung injury | DISEASE | 2 |
adalimumab | CHEMICAL | 2 |
adequacy | PERSON | 2 |
adverse events ctcae | ORG | 2 |
alanine | GPE | 2 |
bbb | ORG | 2 |
alzheimer s | DISEASE | 2 |
amin pharmaceutical company | ORG | 2 |
anakinra | PERSON | 2 |
anticoagulation | CHEMICAL | 2 |
articles | PERSON | 2 |
astrazeneca medimmune boehringer ingelheim | ORG | 2 |
awake prone meta | PERSON | 2 |
azathioprine | CHEMICAL | 2 |
azathioprine azathioprine | PERSON | 2 |
azithromycin tocilizumab | PERSON | 2 |
b11 | ORG | 2 |
comprehensive | ORG | 2 |
coronavirus covid 19 | ORG | 2 |
indonesia | GPE | 2 |
cortiula | ORG | 2 |
gleevec | CHEMICAL | 2 |
gorilla gorilla | CHEMICAL | 2 |
hhk | ORG | 2 |
hit | DISEASE | 2 |
hw | ORG | 2 |
harriett b55 | PERSON | 2 |
health care utilisation questionnaire | ORG | 2 |
helsinki | GPE | 2 |
heterogeneity | ORG | 2 |
hochberg | GPE | 2 |
hoffman | PERSON | 2 |
home plus | ORG | 2 |
home streamlined | ORG | 2 |
huarui sanjiu | PERSON | 2 |
huashan | GPE | 2 |
hubei province | GPE | 2 |
il 17 | ORG | 2 |
ind | ORG | 2 |
inr | ORG | 2 |
ipd | ORG | 2 |
iptw | ORG | 2 |
iv | ORG | 2 |
igm | ORG | 2 |
incidence | ORG | 2 |
individuals | TAXON | 2 |
genv s | LOC | 2 |
genv trials working group | ORG | 2 |
gold | ORG | 2 |
embase | ORG | 2 |
cotrimoxazole | ORG | 2 |
d11 therapeutic | ORG | 2 |
dis | ORG | 2 |
discussion | ORG | 2 |
drc | ORG | 2 |
daegu | PERSON | 2 |
dennis | PERSON | 2 |
diabetes mellitus | PERSON | 2 |
directive | ORG | 2 |
duffett | DISEASE | 2 |
epa | ORG | 2 |
european medicines agency | ORG | 2 |
gm | CHEMICAL | 2 |
examples | ORG | 2 |
experimenter 2 | PERSON | 2 |
fas | ORG | 2 |
fda guidance | ORG | 2 |
fdaaa | ORG | 2 |
fgh | ORG | 2 |
facemasks | ORG | 2 |
feldman | PERSON | 2 |
francisco bautista | PERSON | 2 |
fudan university | ORG | 2 |
glm | ORG | 2 |
sci rep | PERSON | 2 |
md | ORG | 2 |
shuming | CHEMICAL | 2 |
nasal polyps | DISEASE | 2 |
naturalistically | DISEASE | 2 |
nausea | DISEASE | 2 |
neutrophil | GPE | 2 |
nitric oxide | CHEMICAL | 2 |
nodes | CHEMICAL | 2 |
nrnc8u28 | CHEMICAL | 2 |
nucleic acid | CHEMICAL | 2 |
obesity | DISEASE | 2 |
oedema | DISEASE | 2 |
opacity | DISEASE | 2 |
oseltamivir | CHEMICAL | 2 |
ozone | CHEMICAL | 2 |
paclitaxel | CHEMICAL | 2 |
pancreatitis | DISEASE | 2 |
pertussis | DISEASE | 2 |
photophobia | GPE | 2 |
primate | TAXON | 2 |
psoriatic arthritis | DISEASE | 2 |
ranitidine | CHEMICAL | 2 |
rats | TAXON | 2 |
reassortant | TAXON | 2 |
respiratory infection | DISEASE | 2 |
respiratory syndrome mers | DISEASE | 2 |
respiratory syndrome coronavirus 2 sars cov | DISEASE | 2 |
rhesus | TAXON | 2 |
nasal septoplasty | PERSON | 2 |
myocarditis | DISEASE | 2 |
great apes pan paniscus pan troglodytes gorilla gorilla | TAXON | 2 |
multitargeted | CHEMICAL | 2 |
hidradenitis suppurativa | PERSON | 2 |
host | TAXON | 2 |
hypercapnia | GPE | 2 |
hypersensitivity | DISEASE | 2 |
hypotension | DISEASE | 2 |
hypoxemia | DISEASE | 2 |
immunocompromised | DISEASE | 2 |
infected | DISEASE | 2 |
insects | TAXON | 2 |
interferon beta 1b lopinavir ritonavir | CHEMICAL | 2 |
itching rash | DISEASE | 2 |
javanica | TAXON | 2 |
labor | DISEASE | 2 |
lepirudin | PERSON | 2 |
lopinavir | CHEMICAL | 2 |
lung inflammation | DISEASE | 2 |
lung injury | DISEASE | 2 |
malaria infection | DISEASE | 2 |
malignancies | DISEASE | 2 |
mammals | TAXON | 2 |
masculine | CHEMICAL | 2 |
mepolizumab | CHEMICAL | 2 |
mmhg | ORG | 2 |
multiorgan | PERSON | 2 |
multiple myeloma | DISEASE | 2 |
rheumatoid arthritis ra | DISEASE | 2 |
ritonavir | CHEMICAL | 2 |
rotavirus diarrhea | DISEASE | 2 |
s disease | DISEASE | 2 |
the regional committee for medical and health research ethics | ORG | 2 |
the resource utilization | ORG | 2 |
the trial steering committee | ORG | 2 |
the u s food and drug administration | ORG | 2 |
the us fda | ORG | 2 |
the us national institutes of health | ORG | 2 |
the united states food and drug administration | ORG | 2 |
the women s health initiative | ORG | 2 |
the workshop on trade and conservation of pangolins native | ORG | 2 |
the world health organization who | ORG | 2 |
thrombosis | DISEASE | 2 |
toparticipate | CHEMICAL | 2 |
trimoxazole | CHEMICAL | 2 |
tumours | DISEASE | 2 |
twostage | CHEMICAL | 2 |
uk | GPE | 2 |
ustekinumab | CHEMICAL | 2 |
virus disease | DISEASE | 2 |
vitiligo | DISEASE | 2 |
vivo | GPE | 2 |
warfarin | CHEMICAL | 2 |
wildlife | TAXON | 2 |
www medresman org | PERSON | 2 |
sidney farber | PERSON | 2 |
xylometazoline | CHEMICAL | 2 |
the quintet recruitment intervention | ORG | 2 |
the norwegian centre for research data | ORG | 2 |
the national cancer institute | ORG | 2 |
swine | TAXON | 2 |
sarcoma | DISEASE | 2 |
septicaemia | DISEASE | 2 |
septoplasty versus medical | ORG | 2 |
sequellae | DISEASE | 2 |
shortness of breath | DISEASE | 2 |
skin diseases | DISEASE | 2 |
sleep disorder | DISEASE | 2 |
small cell lung cancer | DISEASE | 2 |
stress ulcer | DISEASE | 2 |
sucralfate | CHEMICAL | 2 |
supra infections | DISEASE | 2 |
tamoxifen | CHEMICAL | 2 |
the massachusetts general hospital | ORG | 2 |
the alliance for human research protection | ORG | 2 |
the china clinical trial registry | ORG | 2 |
the creative commons attribution non commercial cc by nc 4 | ORG | 2 |
the danish data protection agency | ORG | 2 |
the danish medicines agency | ORG | 2 |
the data protection regulation | ORG | 2 |
the democratic republic of congo | GPE | 2 |
the ethics committee | ORG | 2 |
the european union | ORG | 2 |
the executive committee of siopen | ORG | 2 |
the international society of dermatology | ORG | 2 |
heparins | CHEMICAL | 2 |
the national institutes of health | ORG | 2 |
gmitz3gg | DISEASE | 2 |
the world health organization | ORG | 2 |
tignanelli | CHEMICAL | 2 |
traditional chinese | ORG | 2 |
truog | PERSON | 2 |
u s fed | ORG | 2 |
ucla | ORG | 2 |
uncover | ORG | 2 |
urti | ORG | 2 |
us fda | ORG | 2 |
us federal reserve | ORG | 2 |
us food and drug administration | ORG | 2 |
usa | GPE | 2 |
viruses | TAXON | 2 |
viscum | PERSON | 2 |
walsham | GPE | 2 |
washington | GPE | 2 |
waste | PERSON | 2 |
west africa | GPE | 2 |
west norway | GPE | 2 |
wiesche | ORG | 2 |
wilcoxon | ORG | 2 |
working groups | ORG | 2 |
wu | PERSON | 2 |
wuhan hubei province | GPE | 2 |
x ray | PERSON | 2 |
zebov | TAXON | 2 |
theoretical | ORG | 2 |
the united states food and drug administration | ORG | 2 |
zelen | ORG | 2 |
the royal children s hospital human research ethics committee | ORG | 2 |
singapore | GPE | 2 |
gastric cancer | DISEASE | 2 |
simplenote | ORG | 2 |
south africa | GPE | 2 |
spray | CHEMICAL | 2 |
statistical | ORG | 2 |
stevens johnson | PERSON | 2 |
stomach cancer | DISEASE | 2 |
studies | ORG | 2 |
subgroup | PERSON | 2 |
suehs | CHEMICAL | 2 |
supplemental methods | ORG | 2 |
surgical | ORG | 2 |
sweden | GPE | 2 |
tcm syndrome | DISEASE | 2 |
tnw | CHEMICAL | 2 |
table 1 | PERSON | 2 |
tams | PERSON | 2 |
target | ORG | 2 |
technical | ORG | 2 |
thailand | GPE | 2 |
thalidomide | CHEMICAL | 2 |
the european medicines agency | ORG | 2 |
the international committee of medical journal editors | ORG | 2 |
the red cross | ORG | 2 |
zmapp | PERSON | 2 |
tf | ORG | 2 |
acute hypoxemic respiratory failure | DISEASE | 2 |
conjugate | CHEMICAL | 2 |
coronavirus sars cov | DISEASE | 2 |
coronavirus crisis | DISEASE | 2 |
corticosteroids | CHEMICAL | 2 |
corvids | TAXON | 2 |
cotrimoxazole | CHEMICAL | 2 |
creatinine | CHEMICAL | 2 |
curcumin resveratrol | PERSON | 2 |
curcumin resveratrol quercetin | CHEMICAL | 2 |
des personnes sud méditerranée i | CHEMICAL | 2 |
digoxin | CHEMICAL | 2 |
discontinuations | DISEASE | 2 |
disease disability | DISEASE | 2 |
distrust | DISEASE | 2 |
dog | TAXON | 2 |
domestic | TAXON | 2 |
drug inherited coagulation abnormalities | DISEASE | 2 |
ec europa eu | ORG | 2 |
elephant | TAXON | 2 |
erectile dysfunction | DISEASE | 2 |
etoposide | CHEMICAL | 2 |
external bony deformity | DISEASE | 2 |
acute respiratory distress syndrome ards | DISEASE | 2 |
fibrosis bronchiectasis | DISEASE | 2 |
fatigue | DISEASE | 2 |
fever cough shortness | DISEASE | 2 |
consumerised | DISEASE | 2 |
dyspnea | DISEASE | 2 |
anakinra kineret | PERSON | 2 |
blurred vision | DISEASE | 2 |
agitation | DISEASE | 2 |
allergy | DISEASE | 2 |
altruism | DISEASE | 2 |
aneurysms | DISEASE | 2 |
angina pectoris | PERSON | 2 |
allergic | DISEASE | 2 |
anomalies | DISEASE | 2 |
arthritis | DISEASE | 2 |
cognitive demands | DISEASE | 2 |
bilirubin | CHEMICAL | 2 |
blood coagulation | DISEASE | 2 |
baloxavir marboxil | CHEMICAL | 2 |
chronic obstructive pulmonary disease copd | DISEASE | 2 |
chronic lung diseases copd asthma bronchiectasis interstitial lung disease | DISEASE | 2 |
clin | PERSON | 2 |
clarithromycin | CHEMICAL | 2 |
carbon dioxide | CHEMICAL | 2 |
al 2018 | PERSON | 2 |
airway inflammation | DISEASE | 2 |
chikungunya | DISEASE | 2 |
cerebrovascular disease | DISEASE | 2 |
cardiomyopathy | DISEASE | 2 |
carboplatin | PERSON | 2 |
llc | CHEMICAL | 1 |
live home path | ORG | 1 |
lib the dignity centre | ORG | 1 |
lhh | ORG | 1 |
lb | GPE | 1 |
l moreno | PERSON | 1 |
kyungpook national university hospital | ORG | 1 |
lm | GPE | 1 |
lazio italy association | ORG | 1 |
kurtycz ross bonnie | PERSON | 1 |
krokeide | CHEMICAL | 1 |
kristine | CHEMICAL | 1 |
kristiansand innovation innovation | ORG | 1 |
kristiansand bergen | PERSON | 1 |
kristian Østergaard nielsen | PERSON | 1 |
lmwh | ORG | 1 |
korica | PERSON | 1 |
korea european union | ORG | 1 |
kong qing mo | PERSON | 1 |
lmh | ORG | 1 |
laufer miriam k chirwa tobias | PERSON | 1 |
lr | ORG | 1 |
lauren hein | PERSON | 1 |
le comité de protection des personnes sud méditerranée | ORG | 1 |
lawrence mathanga don | PERSON | 1 |
klingenberg sarah gluud | PERSON | 1 |
laurie suehs | PERSON | 1 |
laurie pahus | PERSON | 1 |
laurence horby peter olliaro piero | PERSON | 1 |
laurence halimi | PERSON | 1 |
laurence bourdin | PERSON | 1 |
laura drinnan | PERSON | 1 |
lrti | ORG | 1 |
laura devane | PERSON | 1 |
latino | PERSON | 1 |
larson | PERSON | 1 |
lapperre therese | PERSON | 1 |
lapointe | PERSON | 1 |
laplace | ORG | 1 |
langerak 2015 | ORG | 1 |
lancet psychiatry | ORG | 1 |
kong lingwen lv yubao dong jingcheng | PERSON | 1 |
ky 2019299 | CHEMICAL | 1 |
kjerstad egil | CHEMICAL | 1 |
julie gamez anne sophie vachier | PERSON | 1 |
kff | ORG | 1 |
k chirwa tobias | CHEMICAL | 1 |
k barrett 2018 | CHEMICAL | 1 |
k akt | PERSON | 1 |
k 2 | ORG | 1 |
juul sophie nielsen | PERSON | 1 |
jun yu | PERSON | 1 |
julie gottlieb vibeke meteran | PERSON | 1 |
julia | DISEASE | 1 |
kabale highlands | ORG | 1 |
juan ribelles | PERSON | 1 |
juyeun | CHEMICAL | 1 |
joshua m | PERSON | 1 |
joshua lucas sultan hussein mina aries | PERSON | 1 |
joshi keya kahn rebecca vespignani | PERSON | 1 |
lecourt d ed dictionnaire | DISEASE | 1 |
joseph raseta befelatanana | PERSON | 1 |
josefin eklöf | PERSON | 1 |
ky | ORG | 1 |
kai kupferschmidt | PERSON | 1 |
kjell erik | CHEMICAL | 1 |
keywords research | ORG | 1 |
kirkham cruess diamond | PERSON | 1 |
kirchhof mark g title | PERSON | 1 |
kiran angelos | CHEMICAL | 1 |
king abdullah international medical research center | ORG | 1 |
kim | PERSON | 1 |
kieser | LOC | 1 |
kharma nadir | PERSON | 1 |
khadem | CHEMICAL | 1 |
keywords nasal | PERSON | 1 |
kamandi mostafa azimi sajad | PERSON | 1 |
key risk indicators and quality tolerance limits | ORG | 1 |
kenya | GPE | 1 |
keith | PERSON | 1 |
karnofsky | PERSON | 1 |
karmiloff smith | PERSON | 1 |
karmiloff | CHEMICAL | 1 |
kaplan meier | ORG | 1 |
kanchanaburi thailand | PERSON | 1 |
lecourt d ed | PERSON | 1 |
mhv | TAXON | 1 |
lee | PERSON | 1 |
medline | ORG | 1 |
macomber jacobson | PERSON | 1 |
macintyre | ORG | 1 |
mac os x | PERSON | 1 |
mac | PERSON | 1 |
mw | PERSON | 1 |
mri pet | ORG | 1 |
mri | ORG | 1 |
mnar | ORG | 1 |
mmse | ORG | 1 |
mmrm | ORG | 1 |
mir | ORG | 1 |
mip | ORG | 1 |
mhg | ORG | 1 |
mh e mh | CHEMICAL | 1 |
mers infections | DISEASE | 1 |
mers cov infection | DISEASE | 1 |
mers cov mers | ORG | 1 |
mers cov | ORG | 1 |
mers 1 | GPE | 1 |
madagascar madagascar | ORG | 1 |
mady | CHEMICAL | 1 |
magni | PERSON | 1 |
mantel haenszel | PERSON | 1 |
martinsons 2016 | ORG | 1 |
jordan | GPE | 1 |
martin chodorow | PERSON | 1 |
marraro g multicenter | PERSON | 1 |
marnoch | CHEMICAL | 1 |
marignane marignane | CHEMICAL | 1 |
marco luchetti | PERSON | 1 |
mao | PERSON | 1 |
mann whitney u | PERSON | 1 |
magnitude | PERSON | 1 |
mann whitney | PERSON | 1 |
manis javanica | PERSON | 1 |
manis gigantea | PERSON | 1 |
mandourah yasser al mekhlafi | PERSON | 1 |
mallinckrodt | ORG | 1 |
mala | CHEMICAL | 1 |
majid | PERSON | 1 |
mainstage | ORG | 1 |
menm | ORG | 1 |
mec 6 legislation | ORG | 1 |
legare sobel callanan | PERSON | 1 |
mec | CHEMICAL | 1 |
loehr fyfe rittle johnson 2014 | PERSON | 1 |
local institutional review boards | ORG | 1 |
lloyd morgan | PERSON | 1 |
liver and kidney injuries | DISEASE | 1 |
livejournal the verge understanding | ORG | 1 |
little | GPE | 1 |
linux | PERSON | 1 |
linnaeus | PERSON | 1 |
lingwen kong | GPE | 1 |
libron | GPE | 1 |
liberia design | GPE | 1 |
liberia | GPE | 1 |
liang hale michael | PERSON | 1 |
li xin wright david shentu | PERSON | 1 |
leslie mazwi | PERSON | 1 |
lesaffre | PERSON | 1 |
leonardi | GPE | 1 |
lenz | DISEASE | 1 |
lei et al 105 | GPE | 1 |
log | PERSON | 1 |
logistic | ORG | 1 |
logit | ORG | 1 |
mar post | ORG | 1 |
md mf | ORG | 1 |
md kc vn | ORG | 1 |
md kc | ORG | 1 |
mcri | ORG | 1 |
mcf 7 | ORG | 1 |
mcf | CHEMICAL | 1 |
mbsr | ORG | 1 |
masking | CHEMICAL | 1 |
mams | ORG | 1 |
long term oxygen therapy | ORG | 1 |
m y | PERSON | 1 |
lyons young keil | PERSON | 1 |
lynn abernethy amy | PERSON | 1 |
lymphoid leukemia | DISEASE | 1 |
lydia | GPE | 1 |
lung cancer vinorelbine | DISEASE | 1 |
luce 53 | PERSON | 1 |
louisiana | GPE | 1 |
jose jesna al harthy | PERSON | 1 |
ipm a | CHEMICAL | 1 |
joondalup | GPE | 1 |
hydroxychloroquine | CHEMICAL | 1 |
iml conceptualization writing review and editing | ORG | 1 |
il 1beta | ORG | 1 |
il 13 | ORG | 1 |
ictrp see | ORG | 1 |
ics | CHEMICAL | 1 |
icmra | ORG | 1 |
icmje | ORG | 1 |
ice confounding | ORG | 1 |
icd | ORG | 1 |
ibm corp armonk ny usa graphs | ORG | 1 |
hypothetical | ORG | 1 |
hypotension | DISEASE | 1 |
hyponatraemia arthritis | DISEASE | 1 |
hypertensive | DISEASE | 1 |
hypertension | DISEASE | 1 |
hyperglycaemia | DISEASE | 1 |
hydroxychloroquine sulfate | CHEMICAL | 1 |
hydroxychloroquine trial team effects | ORG | 1 |
hydroxychloroquine toxicity | CHEMICAL | 1 |
involve | ORG | 1 |
mashhad university of medical sciences | ORG | 1 |
irbareencouraged investigators | ORG | 1 |
impossible | PERSON | 1 |
india facebook mechanical turk | ORG | 1 |
independent data monitoring committee | ORG | 1 |
independent central | ORG | 1 |
inclusivity sustainability and systematized processes | ORG | 1 |
inclusivity | DISEASE | 1 |
inaccurate | ORG | 1 |
inaba | GPE | 1 |
impressively larotrectinib | PERSON | 1 |
imperial college covid 19 response team the design of clustered observational studies | ORG | 1 |
it a | CHEMICAL | 1 |
impair informativeness | ORG | 1 |
immunological | ORG | 1 |
illustrators | DISEASE | 1 |
identifier | ORG | 1 |
ideally | ORG | 1 |
iucn ssc pangolin specialist group conservation action plan | ORG | 1 |
it outside | CHEMICAL | 1 |
it lapointe | CHEMICAL | 1 |
hydroxychloroquine furthermore | PERSON | 1 |
hutchins enya | CHEMICAL | 1 |
jonsson comprehensive cancer center | ORG | 1 |
husebo | ORG | 1 |
hindex | CHEMICAL | 1 |
hillary bouet marinette | PERSON | 1 |
heparin | ORG | 1 |
henry k beecher | PERSON | 1 |
hennink | ORG | 1 |
hemonc org llc | ORG | 1 |
hemonc org | ORG | 1 |
helen woodward joshua card | PERSON | 1 |
hekkala | PERSON | 1 |
healthcare infection | DISEASE | 1 |
health economics qualitative | ORG | 1 |
health commission of | ORG | 1 |
health care workers | ORG | 1 |
health | ORG | 1 |
headquarters korea pharmaceutical | ORG | 1 |
headaches skin | PERSON | 1 |
hatch waxman act | ORG | 1 |
hassan ameer | PERSON | 1 |
harwood jl abnormal | ORG | 1 |
hiring | PERSON | 1 |
hitchings matthew d t | CHEMICAL | 1 |
hodgkin s disease lymphosarcoma leukemia | DISEASE | 1 |
hu yanhong jessika | PERSON | 1 |
humans | TAXON | 1 |
huguet | ORG | 1 |
hughes | ORG | 1 |
huberman | PERSON | 1 |
hubei | TAXON | 1 |
huashan hospital | PERSON | 1 |
huang qin scutellaria | PERSON | 1 |
huang qi | PERSON | 1 |
hróbjartsson asbjørn | PERSON | 1 |
hodgkin s lymphoma | DISEASE | 1 |
hrubesch preuschoft van schaik 2009 | PERSON | 1 |
hrubesch | ORG | 1 |
honiara solomon islands | GPE | 1 |
hong kong | GPE | 1 |
holtz | PERSON | 1 |
holly melvin lauren | PERSON | 1 |
holly fernandez | PERSON | 1 |
holly beckett tricia tay | PERSON | 1 |
individual n of 1 | ORG | 1 |
infections | DISEASE | 1 |
infectious disease | DISEASE | 1 |
infectious disease | DISEASE | 1 |
jane smith | PERSON | 1 |
james rousseau | PERSON | 1 |
james horby | PERSON | 1 |
james f holland figure | PERSON | 1 |
jaffuel dany marciano | PERSON | 1 |
jacobson hopper 2019 research | ORG | 1 |
jwby bushen yiqi | PERSON | 1 |
jrct japan registry of clinical trials researchers | ORG | 1 |
jpd | ORG | 1 |
jf | ORG | 1 |
jcj bias | PERSON | 1 |
jb clinical | ORG | 1 |
jb | ORG | 1 |
j m p reprints | ORG | 1 |
j l w reprints | ORG | 1 |
j exp child psychol doi | PERSON | 1 |
j arthur adam | PERSON | 1 |
italy ra | DISEASE | 1 |
italy france | GPE | 1 |
janus | GPE | 1 |
jasperson | PERSON | 1 |
jean de dieu | PERSON | 1 |
jicha gregory | PERSON | 1 |
jokhdar | CHEMICAL | 1 |
johnston | PERSON | 1 |
john snow | PERSON | 1 |
john rebecca | PERSON | 1 |
john luce | PERSON | 1 |
john duffett | PERSON | 1 |
joal d dedhia | PERSON | 1 |
jingcheng dong | PERSON | 1 |
jiangsu | GPE | 1 |
jeffrey posner | PERSON | 1 |
jesse gellsinger | PERSON | 1 |
jerome cornfield | PERSON | 1 |
jeremy farrar 5 | PERSON | 1 |
jeon juyeun | PERSON | 1 |
jensen sidse graff | PERSON | 1 |
jensen altschul terrace | PERSON | 1 |
jensen | PERSON | 1 |
jens möller | PERSON | 1 |
italy critical care utilization | ORG | 1 |
italy baseline characteristics | ORG | 1 |
italy 27 | GPE | 1 |
institutional review board irb | ORG | 1 |
interactive | ORG | 1 |
interactions | ORG | 1 |
inter leukin 6 | ORG | 1 |
intention | ORG | 1 |
integrative cancer therapies learning | ORG | 1 |
integrative | ORG | 1 |
integr cancer | DISEASE | 1 |
institutional review board irb independent ethics committee iec | ORG | 1 |
institutional ethics committees | ORG | 1 |
interferon beta 1a chloroquine | CHEMICAL | 1 |
institutional | ORG | 1 |
institut pasteur de madagascar centre | ORG | 1 |
ingraham nicholas | PERSON | 1 |
ingraham dr ingraham | ORG | 1 |
information technology it | ORG | 1 |
influenza infection | DISEASE | 1 |
infliximab | CHEMICAL | 1 |
inference missing data | ORG | 1 |
interdisciplinary maternal perinatal australasian collaborative trials impact | ORG | 1 |
interim | ORG | 1 |
israel | GPE | 1 |
intestinal symptoms diarrhoea vomiting fever | DISEASE | 1 |
isabelle molinari nicolas | PERSON | 1 |
ipilimumab | CHEMICAL | 1 |
ipads | PERSON | 1 |
iowa | GPE | 1 |
inès vigan womas | PERSON | 1 |
investigational medicinal products | ORG | 1 |
inverse | ORG | 1 |
intussusception | DISEASE | 1 |
interventional | ORG | 1 |
interim healthcare infection prevention and control recommendations for patients under investigation | ORG | 1 |
intervention | ORG | 1 |
international registry recovery | ORG | 1 |
international conference on harmonisation expert working group 1996 international conference on harmonisation guideline for good clinical practice e6 | ORG | 1 |
international classification of functioning disability | ORG | 1 |
international classification of diseases 11th | ORG | 1 |
international | ORG | 1 |
intermediate | ORG | 1 |
interleukin 1 | ORG | 1 |
marusich | CHEMICAL | 1 |
ni | ORG | 1 |
mashhad university of medical sciences mashhad | ORG | 1 |
picu | ORG | 1 |
papua new guinea | GPE | 1 |
pankaj chaturvedi | ORG | 1 |
pangolins science society and conservation meat | ORG | 1 |
pangolin conservation program | ORG | 1 |
panel | ORG | 1 |
palfai | CHEMICAL | 1 |
pakistan | GPE | 1 |
paeonol | CHEMICAL | 1 |
paeoniae rubra radix | CHEMICAL | 1 |
pao2 fio2 p f ratio | ORG | 1 |
pao 2 fio 2 | ORG | 1 |
pao | ORG | 1 |
ps 341 | PERSON | 1 |
prowess shock study group | ORG | 1 |
protoaccept | ORG | 1 |
prisma | PERSON | 1 |
po ag te | CHEMICAL | 1 |
po ag | ORG | 1 |
po | ORG | 1 |
parallel group trial hydroxychloroquine | ORG | 1 |
parents | ORG | 1 |
parntep ratanakorn | ORG | 1 |
peru | GPE | 1 |
phenylalanine | CHEMICAL | 1 |
phase 2 and 24 | ORG | 1 |
phase 2 | ORG | 1 |
phase 1 | GPE | 1 |
peter w | PERSON | 1 |
peter mcculloch | PERSON | 1 |
peter grabitz | PERSON | 1 |
peter b23 | PERSON | 1 |
perth western australia | GPE | 1 |
participants | PERSON | 1 |
pembrolizumab keynote | ORG | 1 |
peiru yu | PERSON | 1 |
pearson s | ORG | 1 |
pavlou | PERSON | 1 |
patson noel mukaka mavuto otwombe kennedy | PERSON | 1 |
patient | PERSON | 1 |
pascale | PERSON | 1 |
pascal chanez | PERSON | 1 |
pmid | ORG | 1 |
picot | ORG | 1 |
novartis astrazeneca roche genentech | ORG | 1 |
pf | ORG | 1 |
oncologic | ORG | 1 |
omegaven | PERSON | 1 |
oliver djurhuus | PERSON | 1 |
olga quan hui li | PERSON | 1 |
oklahoma | GPE | 1 |
oecophylla | PERSON | 1 |
oceania 2 | LOC | 1 |
observational | ORG | 1 |
observable | ORG | 1 |
objectives several | ORG | 1 |
obesity | DISEASE | 1 |
orr of 80 | ORG | 1 |
origins | ORG | 1 |
orchid protocol committee | ORG | 1 |
omp | ORG | 1 |
oda | CHEMICAL | 1 |
oces | ORG | 1 |
nurse led | ORG | 1 |
nurs | CHEMICAL | 1 |
ontario | GPE | 1 |
operational issues | ORG | 1 |
oral tecovirimat | ORG | 1 |
oxford university a statistical analysis | ORG | 1 |
pet | ORG | 1 |
pde4 | CHEMICAL | 1 |
pd l1 | ORG | 1 |
pcori | ORG | 1 |
path | PERSON | 1 |
pam | CHEMICAL | 1 |
p f ratio | ORG | 1 |
oxygen | CHEMICAL | 1 |
ovid healthstar | PERSON | 1 |
oregon | GPE | 1 |
ovid | ORG | 1 |
outcomes | ORG | 1 |
outbreaks | TAXON | 1 |
our world | ORG | 1 |
otwombe | CHEMICAL | 1 |
otolaryngol head | PERSON | 1 |
osteoarthritis | DISEASE | 1 |
organisational | ORG | 1 |
philadelphia | GPE | 1 |
philippe ripoll pierre barnier julien vuillemot romain | PERSON | 1 |
pholidata manidae | ORG | 1 |
pholidota | CHEMICAL | 1 |
radiotherapy | PERSON | 1 |
rss | ORG | 1 |
rsi | ORG | 1 |
rna | ORG | 1 |
rit4237 | DISEASE | 1 |
reform | PERSON | 1 |
rec | GPE | 1 |
rdt rapid | ORG | 1 |
rca np | ORG | 1 |
rapidd | ORG | 1 |
r1 addendum | PERSON | 1 |
qualtrics personality | ORG | 1 |
qualtrics | ORG | 1 |
quality adjusted life year qaly | ORG | 1 |
qualitative health research human documents research | ORG | 1 |
qing kong | GPE | 1 |
qi gong | PERSON | 1 |
qi eric | PERSON | 1 |
qi | PERSON | 1 |
rafael mahillo | PERSON | 1 |
rafatpanah houshang khatami | PERSON | 1 |
rahimi | PERSON | 1 |
ratitch et al 2013 | PERSON | 1 |
harriett s | GPE | 1 |
reduced | PERSON | 1 |
redcap | ORG | 1 |
recommendations | ORG | 1 |
recomendaciones sobre el | PERSON | 1 |
re zheng | PERSON | 1 |
ray | PERSON | 1 |
ravaka mayouya | PERSON | 1 |
rasi guido | PERSON | 1 |
rai ansaar | ORG | 1 |
rapid | ORG | 1 |
randria | GPE | 1 |
randremanana rindra vatosoa | PERSON | 1 |
randomized | PERSON | 1 |
randomization registry | ORG | 1 |
randolph adrienne cook | PERSON | 1 |
rajendran | CHEMICAL | 1 |
raina chughtai | PERSON | 1 |
qalys | ORG | 1 |
qaly | ORG | 1 |
q qat quanti | PERSON | 1 |
pongo pygmaeus | TAXON | 1 |
precision medicine | ORG | 1 |
precision clinical medicine | ORG | 1 |
poynard | PERSON | 1 |
posterous | CHEMICAL | 1 |
posch | PERSON | 1 |
porphyria hypoglycaemia myopathy extrapyramidal genes cramps neuropathy palsy psychosis | DISEASE | 1 |
porphyria hypoglycaemia | DISEASE | 1 |
poole | ORG | 1 |
pongo abelii | TAXON | 1 |
pregnancy library | ORG | 1 |
poisson | PERSON | 1 |
plasmodium falciparum malaria infection | DISEASE | 1 |
plasmodium falciparum malaria | DISEASE | 1 |
plasma concentrations | PERSON | 1 |
plasma | PERSON | 1 |
pinsonneault 1998 desanctis | ORG | 1 |
pilkington | GPE | 1 |
pilgrims | CHEMICAL | 1 |
pregnancy | GPE | 1 |
prevalence | PERSON | 1 |
putri | CHEMICAL | 1 |
protection of human | ORG | 1 |
put | CHEMICAL | 1 |
publisher s note springer nature | ORG | 1 |
public distrust | DISEASE | 1 |
psychiatric | DISEASE | 1 |
psonet | PERSON | 1 |
protocols | ORG | 1 |
protocol hydroxychloroquine | LOC | 1 |
protezione civile | ORG | 1 |
protecting | ORG | 1 |
primary publications | ORG | 1 |
protect prostate | CHEMICAL | 1 |
protect prostate | CHEMICAL | 1 |
proschan 2012 | CHEMICAL | 1 |
proschan | PERSON | 1 |
proportion of | ORG | 1 |
prophylaxis supplementary | GPE | 1 |
prolonged qt | ORG | 1 |
productos | CHEMICAL | 1 |
novartis dr | PERSON | 1 |
notwithstanding | ORG | 1 |
mathanga | CHEMICAL | 1 |
mindfulness stress reduction course | ORG | 1 |
montpellier | GPE | 1 |
mometasone furoate | CHEMICAL | 1 |
mometasone nasal spray | PERSON | 1 |
molloy | PERSON | 1 |
mohand | GPE | 1 |
mohammed mady ahmed fowler | PERSON | 1 |
mohammad moeini | PERSON | 1 |
mohamed bajhmom wail hussein mohamed | PERSON | 1 |
modes | CHEMICAL | 1 |
mobilization observation behavior intensity dementia pain scale mobid | ORG | 1 |
mobile it publisher s note springer nature | ORG | 1 |
mitchell turaga kiran | PERSON | 1 |
missing data a general statistical principle for changing a design any time during the course of a trial robust inference | ORG | 1 |
mische | CHEMICAL | 1 |
minoarisoa | TAXON | 1 |
minnesota | GPE | 1 |
ministry health and welfare daily | ORG | 1 |
ministri dipartimento | PERSON | 1 |
mini mental state | ORG | 1 |
morrison 2015 | ORG | 1 |
mortazi | CHEMICAL | 1 |
mortazi hassan | PERSON | 1 |
mycophenolate mofetil | CHEMICAL | 1 |
n 1308 table 2 characteristics of assessed interventions | CHEMICAL | 1 |
n 1308 table 2 characteristics | ORG | 1 |
n 1308 | ORG | 1 |
n 1 | ORG | 1 |
møller ulla weinrich sverrild | CHEMICAL | 1 |
mäkelä | GPE | 1 |
myeloid leukemia breast | PERSON | 1 |
mycophenolate mofetil cellcept | CHEMICAL | 1 |
myasthenia gravis | DISEASE | 1 |
mount sinai | LOC | 1 |
myasthenia | GPE | 1 |
myd88 | PERSON | 1 |
muzhda sonne | CHEMICAL | 1 |
murdoch children | PERSON | 1 |
mundipharma | ORG | 1 |
mun dipharma | PERSON | 1 |
multicenter collaboration group of department of science and technology of | ORG | 1 |
mount sinai hospital | ORG | 1 |
miner | PERSON | 1 |
miller | ORG | 1 |
north tyneside 2 | LOC | 1 |
miles | PERSON | 1 |
medical research council | ORG | 1 |
med res methodol | PERSON | 1 |
med lausanne | PERSON | 1 |
med j | PERSON | 1 |
med ethics | PERSON | 1 |
measles | ORG | 1 |
mesh | ORG | 1 |
mchugh ml interrater | PERSON | 1 |
mcguigan núñez 2006 | ORG | 1 |
mcculloch peter sedrakyan art | PERSON | 1 |
mazzarella luca title semantic | CHEMICAL | 1 |
mazzarella luca | PERSON | 1 |
maximizing independence at | ORG | 1 |
matthieu baril | PERSON | 1 |
matthew rudolph | PERSON | 1 |
matthew d t | PERSON | 1 |
matt hazzard | PERSON | 1 |
mathilde el | CHEMICAL | 1 |
mathematical | ORG | 1 |
medication review organization of activities | ORG | 1 |
medicine survive | ORG | 1 |
melanoma | DISEASE | 1 |
michael orsini | PERSON | 1 |
milan s emergency medical system | ORG | 1 |
mike clarke | PERSON | 1 |
mike bray alison | PERSON | 1 |
mike bray | CHEMICAL | 1 |
middleinitial | ORG | 1 |
middle east respiratory syndrome covid 19 | LOC | 1 |
middle east respiratory syndrome | LOC | 1 |
microsoft | ORG | 1 |
miami | GPE | 1 |
melissa schmitt peter moller | PERSON | 1 |
mipl | CHEMICAL | 1 |
meyer | PERSON | 1 |
mexico | GPE | 1 |
meteran | CHEMICAL | 1 |
metaanalysis | GPE | 1 |
messages | ORG | 1 |
meredith halimi | PERSON | 1 |
melissa wake | PERSON | 1 |
n 1308 table 3 provide a re categorization of | CHEMICAL | 1 |
n 2 | ORG | 1 |
n 2716 9 | CHEMICAL | 1 |
n 685 2 3 | CHEMICAL | 1 |
neurovascular fremont | PERSON | 1 |
neurointerv surg | PERSON | 1 |
neurogenic hearing loss psoriasis retinopathy | DISEASE | 1 |
neurogenic | ORG | 1 |
neuroendovascular | PERSON | 1 |
network | ORG | 1 |
nervousness somnolence | DISEASE | 1 |
neisseriae meningitidis | PERSON | 1 |
neisseria | GPE | 1 |
negative | ORG | 1 |
neck surg | PERSON | 1 |
neck doi | PERSON | 1 |
nebraska | GPE | 1 |
navajo | GPE | 1 |
nature | ORG | 1 |
national trust for nature conservation lalitpur morphometrics | ORG | 1 |
national institutes of health and national heart lung and blood institute | ORG | 1 |
national institute on aging | ORG | 1 |
national health systems | ORG | 1 |
new england journal of medicine | ORG | 1 |
new york | GPE | 1 |
new york city | GPE | 1 |
noferesti | CHEMICAL | 1 |
north jakarta | GPE | 1 |
north east | LOC | 1 |
north dakota | GPE | 1 |
north america usa | LOC | 1 |
norman zhao peng | PERSON | 1 |
normalisation process theory | ORG | 1 |
non bayesian | PERSON | 1 |
non | ORG | 1 |
nodeh | CHEMICAL | 1 |
newcastle | GPE | 1 |
nitrogen | ORG | 1 |
nigeria monthly | PERSON | 1 |
nicolas m | ORG | 1 |
nicholas devito | PERSON | 1 |
nguyen van | PERSON | 1 |
nguyen oikonomidi | PERSON | 1 |
ng | CHEMICAL | 1 |
next | ORG | 1 |
national commission for the protection of human subjects | ORG | 1 |
natalie hutchins enya meade | PERSON | 1 |
natalie e | CHEMICAL | 1 |
nct04110340 | CHEMICAL | 1 |
ned | ORG | 1 |
ne | CHEMICAL | 1 |
nct04445935 | DISEASE | 1 |
nct04357782 | CHEMICAL | 1 |
nct04322396 | CHEMICAL | 1 |
nct04280705 fda | ORG | 1 |
nct04280705 | CHEMICAL | 1 |
nct04110340 registered | PERSON | 1 |
nct04043364 | CHEMICAL | 1 |
nhs foundation trust | ORG | 1 |
nct03680274 | CHEMICAL | 1 |
nct03098303 anonymous | ORG | 1 |
nct02845843 registered | ORG | 1 |
nct02845843 | CHEMICAL | 1 |
ncorp | ORG | 1 |
nairos authors | ORG | 1 |
n a | CHEMICAL | 1 |
n 8511 | CHEMICAL | 1 |
nf | ORG | 1 |
nia | CHEMICAL | 1 |
nasrallah ali | PERSON | 1 |
nvivo | ORG | 1 |
nasendoscopic | ORG | 1 |
nasal spray | PERSON | 1 |
nasal polyposis | DISEASE | 1 |
nasal obstruction symptom evaluation scale nose | ORG | 1 |
nasal airway obstruction study nairos | ORG | 1 |
nancy giaglis george m wareham jonathan | PERSON | 1 |
nyt tracker | CHEMICAL | 1 |
nyt | CHEMICAL | 1 |
nv1 | ORG | 1 |
nih common data element research portal | ORG | 1 |
numbers to | CHEMICAL | 1 |
noac | ORG | 1 |
nks olaviken gerontopsychiatric hospital | ORG | 1 |
niv respirator | ORG | 1 |
nimp | ORG | 1 |
nihr clrn | ORG | 1 |
nihr c for de | ORG | 1 |
nih other us federal agency | ORG | 1 |
harvard university yale university | ORG | 1 |
bogaerts komarek | PERSON | 1 |
harmonisation of technical requirements for registration of pharmaceuticals for | ORG | 1 |
bradford north england | ORG | 1 |
cioms council of international organizations of | ORG | 1 |
cioms | ORG | 1 |
che ii | CHEMICAL | 1 |
cfr | ORG | 1 |
c test | ORG | 1 |
c jun | ORG | 1 |
buyse marc | PERSON | 1 |
burton jones | PERSON | 1 |
burkina faso | GPE | 1 |
burdett mcguigan | PERSON | 1 |
burden | ORG | 1 |
bubonic | ORG | 1 |
bu fei yi shen | PERSON | 1 |
bu | CHEMICAL | 1 |
brussels european medicines agency points | ORG | 1 |
brosnan hopper 2014 | GPE | 1 |
british medical research council | ORG | 1 |
bristol university | ORG | 1 |
breast cancer colon cancer | DISEASE | 1 |
ckj | CHEMICAL | 1 |
cml | DISEASE | 1 |
columbus | ORG | 1 |
covid 19 comparative | ORG | 1 |
covid 19 risk | ORG | 1 |
covid 19 relevant | ORG | 1 |
covid 19 public health emergency guidance | ORG | 1 |
covid 19 merchant | ORG | 1 |
covid 19 mental | ORG | 1 |
covid 19 letter | ORG | 1 |
covid 19 epidemiological | ORG | 1 |
covid 19 compensation | ORG | 1 |
covid 19 characteristics of ischaemic | ORG | 1 |
consort extension for trials using cohorts and routinely collected health data spirit and template for intervention description and replication | ORG | 1 |
covid 19 association | ORG | 1 |
covid 19 6 | ORG | 1 |
covid 19 19 | ORG | 1 |
covid 19 11 | ORG | 1 |
covid 19 1 2 4 | ORG | 1 |
covid 19 1 | ORG | 1 |
cosmos | PERSON | 1 |
cop trin | CHEMICAL | 1 |
breast cancer | DISEASE | 1 |
bradford | GPE | 1 |
baloxavir marboxil | CHEMICAL | 1 |
boujan | CHEMICAL | 1 |
benjamini | PERSON | 1 |
benjamin f cowan | PERSON | 1 |
benelux scandinavia | PERSON | 1 |
benelux | GPE | 1 |
benefits | ORG | 1 |
ben michael eli feller avi | PERSON | 1 |
belloni fortina | PERSON | 1 |
behcet syndrome | DISEASE | 1 |
behcet | GPE | 1 |
behaviors | ORG | 1 |
behavioral conservatism | DISEASE | 1 |
behavioral research 1979 | ORG | 1 |
bayer amgen sanofi | ORG | 1 |
bates maechler | PERSON | 1 |
baseline | ORG | 1 |
barrett | PERSON | 1 |
barnett | PERSON | 1 |
baojun liu yijie du | PERSON | 1 |
bangkok | GPE | 1 |
bentzer peter | PERSON | 1 |
bettina sandgathe allore heather achterberg wilco | PERSON | 1 |
beyond | ORG | 1 |
boehringer ingeheim almirall | ORG | 1 |
boudreau | PERSON | 1 |
born | GPE | 1 |
boren | PERSON | 1 |
bonferroni | PERSON | 1 |
bonawitz | ORG | 1 |
bojesen rasmus | PERSON | 1 |
bohdana wolbers | PERSON | 1 |
regulatory agencies | ORG | 1 |
board on health sciences policy forum | ORG | 1 |
bias | PERSON | 1 |
blog | PERSON | 1 |
block keith | PERSON | 1 |
biosciences sharon | PERSON | 1 |
biomedical | GPE | 1 |
biomarker | ORG | 1 |
bio pharma manufacturers association integrated drug information | ORG | 1 |
bilalić | GPE | 1 |
bibliometrics global | PERSON | 1 |
covid 19 tsiodras s escmid study group for respiratory viruses review | ORG | 1 |
covid 19 coronavirus diseaes | DISEASE | 1 |
covid 19 disease | DISEASE | 1 |
covid 19 vaccine 44 | ORG | 1 |
chinese state council | ORG | 1 |
china world health organization novel | ORG | 1 |
china world | ORG | 1 |
china sars cov 2 | ORG | 1 |
china korea | GPE | 1 |
china granule | ORG | 1 |
chimpanzees pan | PERSON | 1 |
chimpanzees | ORG | 1 |
chiesi | ORG | 1 |
chicago il usa | ORG | 1 |
chictr2000029544 | GPE | 1 |
chi shao paeoniae | PERSON | 1 |
chen siegler daehler | PERSON | 1 |
chen daohong | PERSON | 1 |
chelsea | ORG | 1 |
chaturvedi https orcid org 0000 0002 | DISEASE | 1 |
characteristics | PERSON | 1 |
chang | PERSON | 1 |
chanez | DISEASE | 1 |
chloroquine diphosphate | CHEMICAL | 1 |
chloroquine diphosphate | CHEMICAL | 1 |
chloroquine diphosphate cq | CHEMICAL | 1 |
chronic obstructive pulmonary disease | DISEASE | 1 |
clemens john d ochiai | PERSON | 1 |
cleanspace technology | ORG | 1 |
claudio ciborra resist | PERSON | 1 |
claudio ciborra | CHEMICAL | 1 |
claudia bonnet | DISEASE | 1 |
clark 1987 studies | ORG | 1 |
citrix | ORG | 1 |
chronic obstructive pulmonary disease copd | DISEASE | 1 |
chronic rhinosinusitis | DISEASE | 1 |
chloroquine hydroxychloroquine | CHEMICAL | 1 |
chronic obstructive pulmonary disease copd | DISEASE | 1 |
chronic obstructive lung disease | DISEASE | 1 |
chromatin | PERSON | 1 |
christine toumani farouk | PERSON | 1 |
christian jakobsen | PERSON | 1 |
chris brough paula | PERSON | 1 |
chowdhery | DISEASE | 1 |
choudrie | PERSON | 1 |
chance | PERSON | 1 |
chahrour mohamad a salhab hamza a fares mohammad y khachfe hussein h akl | ORG | 1 |
chahrour | DISEASE | 1 |
cabanac guillaume chaimani anna | PERSON | 1 |
canis familiaris | PERSON | 1 |
candice abraham | PERSON | 1 |
cancer ther | PERSON | 1 |
canberra doh data integrity | ORG | 1 |
canadian critical care trials group | ORG | 1 |
camponotus | ORG | 1 |
callaway | GPE | 1 |
calcium | CHEMICAL | 1 |
cvd103 hgr | LOC | 1 |
capuchin | PERSON | 1 |
cs | ORG | 1 |
crp | ORG | 1 |
crd42020178787 | CHEMICAL | 1 |
crd42019120916 | DISEASE | 1 |
communication systematic | ORG | 1 |
cox 2 | ORG | 1 |
covid 19 | ORG | 1 |
covid infection | DISEASE | 1 |
captive chimpanzee | TAXON | 1 |
card fail rev | ORG | 1 |
cerenovus | GPE | 1 |
casey | PERSON | 1 |
centres de santé de base csb | ORG | 1 |
central ethics committee | ORG | 1 |
central disaster management headquarters central disease control | ORG | 1 |
centers for disease control and prevention | ORG | 1 |
cell actelion merck roche chiesi | ORG | 1 |
celgene | GPE | 1 |
catherine dominic | PERSON | 1 |
castañeda a | DISEASE | 1 |
case fatality rate and characteristics of patients dying in relation | ORG | 1 |
cardiovascular | ORG | 1 |
carsten hjorthøj | PERSON | 1 |
carpenter | PERSON | 1 |
carolina grasselli | PERSON | 1 |
carey suehs | PERSON | 1 |
care med doi | PERSON | 1 |
care | PERSON | 1 |
cardiovascular disease | DISEASE | 1 |
cardiovascular clinical trials | ORG | 1 |
baltimore | GPE | 1 |
balas | PERSON | 1 |
clin exp res | PERSON | 1 |
aifa italian medical agency | ORG | 1 |
acute lung injury petal network investigators rationale | ORG | 1 |
acute copd | ORG | 1 |
accounting management and information technologies | ORG | 1 |
access | ORG | 1 |
abrar ahmad chughtai | PERSON | 1 |
abrar ahmad | PERSON | 1 |
abraham | PERSON | 1 |
abdullah m aziz jokhdar | PERSON | 1 |
abdominal pain | DISEASE | 1 |
azd1775 | CHEMICAL | 1 |
ax100 | CHEMICAL | 1 |
auc | ORG | 1 |
asco | ORG | 1 |
ards management characteristics | ORG | 1 |
ards network | ORG | 1 |
ank | ORG | 1 |
ampk | ORG | 1 |
alveoli | ORG | 1 |
alk aberrations 2 32 | ORG | 1 |
acute physiology and chronic health evaluation | ORG | 1 |
acute respiratory failure | DISEASE | 1 |
adalimumab injection | ORG | 1 |
agile | GPE | 1 |
al dawood | PERSON | 1 |
akt nf | PERSON | 1 |
akt | PERSON | 1 |
akbar hospital | ORG | 1 |
airborne | PERSON | 1 |
ahmadabad | CHEMICAL | 1 |
agreed | PERSON | 1 |
agility | DISEASE | 1 |
agenzia italiana del farmaco aifa | ORG | 1 |
adaptation | ORG | 1 |
agencia española de medicamentos | PERSON | 1 |
agence nationale de la recherche | ORG | 1 |
age baseline | ORG | 1 |
aff millwood | CHEMICAL | 1 |
aesculus hippocastanum | TAXON | 1 |
adult | PERSON | 1 |
adjunctive | ORG | 1 |
adaptive structuration theory | ORG | 1 |
alat inr | ORG | 1 |
aids | DISEASE | 1 |
bakdash marusich | ORG | 1 |
ai139761 | CHEMICAL | 1 |
80405 | DISEASE | 1 |
8 sha 7d0ca6f12ca511ee15ba18a6c8d2aa24e817c38c | CHEMICAL | 1 |
8 sha 66135485fd2c4e5e731cdeccedbfec45b3a0b1ee doc_id 310272 | CHEMICAL | 1 |
7 medications | ORG | 1 |
7 data | ORG | 1 |
5705 | DISEASE | 1 |
5 fu fluorouracil | CHEMICAL | 1 |
4 post | ORG | 1 |
338588 | DISEASE | 1 |
334667 | CHEMICAL | 1 |
331487 cord_uid | CHEMICAL | 1 |
322534 | DISEASE | 1 |
3 7643 7381 4_11 sha 163bcb2af847d6eb88ddfa45d0a38857809415f5 | CHEMICAL | 1 |
294651 | DISEASE | 1 |
266573 | DISEASE | 1 |
263088 | DISEASE | 1 |
261605 haraldsplass deaconess hospital | ORG | 1 |
20e | CHEMICAL | 1 |
2019 hovav | PERSON | 1 |
8119 | DISEASE | 1 |
99mtc | CHEMICAL | 1 |
9tetrahydrocannabinol creatinine | CHEMICAL | 1 |
ac multiple | ORG | 1 |
ag057461 | CHEMICAL | 1 |
ag028383 | CHEMICAL | 1 |
ag | CHEMICAL | 1 |
adamon | ORG | 1 |
actt | ORG | 1 |
acth | ORG | 1 |
ace | ORG | 1 |
acc tumors | DISEASE | 1 |
ab | ORG | 1 |
a bibliometric analysis | ORG | 1 |
aacr | ORG | 1 |
aac | ORG | 1 |
a practical guide through qualitative analysis strategic | ORG | 1 |
a practical guide using | ORG | 1 |
a european directive | ORG | 1 |
a data and safety monitoring board | ORG | 1 |
a data safety monitoring board | ORG | 1 |
a cañete | ORG | 1 |
al sulaiman | PERSON | 1 |
alnaamani khalid alsinani siham barkun alan n | ORG | 1 |
alblas | PERSON | 1 |
ali kharaba | PERSON | 1 |
aïda | DISEASE | 1 |
azitro | GPE | 1 |
automatic | PERSON | 1 |
australia s therapeutic goods administration | ORG | 1 |
austin bradford hill | PERSON | 1 |
astrid cohen boulakia | PERSON | 1 |
astrazeneca medimmune boehringer | ORG | 1 |
assortative | LOC | 1 |
association of treatment | ORG | 1 |
asociación | DISEASE | 1 |
asiri ayed | DISEASE | 1 |
asia south africa europe | LOC | 1 |
asger jensen | PERSON | 1 |
asbjørn julia | CHEMICAL | 1 |
arthralgia headaches | PERSON | 1 |
art sedrakyan | PERSON | 1 |
arnaud bourdin | PERSON | 1 |
arkansas | GPE | 1 |
ari chen | PERSON | 1 |
b chloroethyl amines | CHEMICAL | 1 |
b11 users | ORG | 1 |
b19 apple | ORG | 1 |
bmc | ORG | 1 |
baillargeon hanko summers | ORG | 1 |
baerum | ORG | 1 |
background septoplasty | PERSON | 1 |
by | ORG | 1 |
bpsd | ORG | 1 |
bnp | ORG | 1 |
bmj publishing group ltd | ORG | 1 |
bmj | ORG | 1 |
bih | DISEASE | 1 |
b55 | GPE | 1 |
bicr | ORG | 1 |
bd | GPE | 1 |
bc children s hospital research institute | ORG | 1 |
bat | ORG | 1 |
b99 | ORG | 1 |
b80 b11 | ORG | 1 |
b67 trial | PERSON | 1 |
b67 appropriation | ORG | 1 |
argatroban | CHEMICAL | 1 |
arbidol | PERSON | 1 |
arabia | TAXON | 1 |
alzheimer s disease | DISEASE | 1 |
anaphylactic reaction | DISEASE | 1 |
analyze | ORG | 1 |
an urgent call for raising the scientific rigorousness of clinical trials | ORG | 1 |
amgen | ORG | 1 |
american thoracic society | ORG | 1 |
american society of clinical oncology s | ORG | 1 |
ameer e | CHEMICAL | 1 |
alzheimers | DISEASE | 1 |
alzheimer s association | ORG | 1 |
andrew greer john p fernandes | PERSON | 1 |
alstrup gitte | PERSON | 1 |
allocation | ORG | 1 |
allergy | DISEASE | 1 |
allergic reactions angioedema hypersensitivity | DISEASE | 1 |
allergic reactions | DISEASE | 1 |
allergic | PERSON | 1 |
allahyari abolghasem | PERSON | 1 |
alight | CHEMICAL | 1 |
andrea daniele | PERSON | 1 |
andrew j | PERSON | 1 |
arabi yaseen m asiri | PERSON | 1 |
appendix 13 | ORG | 1 |
arabi yaseen | CHEMICAL | 1 |
apremilast | ORG | 1 |
appropriating information technology artefacts | ORG | 1 |
approaches | ORG | 1 |
application of resource utilization | ORG | 1 |
applicability | ORG | 1 |
apple inc | ORG | 1 |
appendix data | ORG | 1 |
anxiety | DISEASE | 1 |
andrew michalski | PERSON | 1 |
ants wasps | TAXON | 1 |
ants | TAXON | 1 |
anne marie hanson baerum | PERSON | 1 |
anna | PERSON | 1 |
ann surg | PERSON | 1 |
ann marie holstein eva maria | PERSON | 1 |
anita krokeide bergen | PERSON | 1 |
angelos peter | PERSON | 1 |
clin cases | PERSON | 1 |
clin infect dis doi | PERSON | 1 |
harborough | CHEMICAL | 1 |
extracorporeal | ORG | 1 |
fehizoro | CHEMICAL | 1 |
federica gandini | PERSON | 1 |
federica corso | PERSON | 1 |
federal regulations for the protection of human | ORG | 1 |
febuxostat | CHEMICAL | 1 |
farran | CHEMICAL | 1 |
fargen | CHEMICAL | 1 |
faisal aldabi asjad smain osamah a m lance marcus | PERSON | 1 |
fagot meguerditchian | PERSON | 1 |
fvc | ORG | 1 |
fo mp | CHEMICAL | 1 |
findings | ORG | 1 |
fdr | PERSON | 1 |
fda food | ORG | 1 |
fda european medicines agency ema | ORG | 1 |
fc | GPE | 1 |
face masks | CHEMICAL | 1 |
fa brca | CHEMICAL | 1 |
f bautista | PERSON | 1 |
fei tang | PERSON | 1 |
felix carol | PERSON | 1 |
feno rakotoarimanana | PERSON | 1 |
fluctuating | PERSON | 1 |
freeman | ORG | 1 |
fraser justin f hirsch joshua | PERSON | 1 |
franklin marshall college | ORG | 1 |
franklin marshall | PERSON | 1 |
fortina | DISEASE | 1 |
formerly | PERSON | 1 |
food and drug administration | ORG | 1 |
focus area | ORG | 1 |
florida | GPE | 1 |
feras | CHEMICAL | 1 |
fishers | PERSON | 1 |
fiorella | CHEMICAL | 1 |
finland | GPE | 1 |
findability | DISEASE | 1 |
fernández ignacio | ORG | 1 |
fernandez lynch h | ORG | 1 |
fernandes hermina d | CHEMICAL | 1 |
fernandes 2005 | PERSON | 1 |
f | PERSON | 1 |
extra copd | ORG | 1 |
elie dit | PERSON | 1 |
explor | DISEASE | 1 |
eran | CHEMICAL | 1 |
equally | PERSON | 1 |
equalcontrib | ORG | 1 |
eosinophilia leukopenia neutropenia | DISEASE | 1 |
envelopes | LOC | 1 |
enterprise resource planning erp systems contemporary devices | ORG | 1 |
ensemble forecasts | PERSON | 1 |
englert stefan shen wei dey jyotirmoy liu | PERSON | 1 |
endpoints estimands analysis strategies | ORG | 1 |
empowerment at home pathway | ORG | 1 |
emmanuel conil | PERSON | 1 |
emily nielsen | PERSON | 1 |
embase | ORG | 1 |
elyazal | CHEMICAL | 1 |
elshafei moustafa sayed | PERSON | 1 |
elizabeth quirke fiona | PERSON | 1 |
elizabeth halloran m longini ira m | PERSON | 1 |
elizabeth | PERSON | 1 |
eligible | ORG | 1 |
eran yashiv | PERSON | 1 |
erich jaeger | PERSON | 1 |
erik gedde | PERSON | 1 |
european respiratory clinical journal | ORG | 1 |
expert | PERSON | 1 |
experimenter | PERSON | 1 |
exfoliative dermatitis erythema multiforme photosensitivity stevens johnson syndrome toxic | DISEASE | 1 |
executive | ORG | 1 |
except | PERSON | 1 |
eusapharma | ORG | 1 |
eusa pharma | ORG | 1 |
european union | ORG | 1 |
european directive | ORG | 1 |
erik julius | PERSON | 1 |
european commission | ORG | 1 |
eudralex vol 10 | PERSON | 1 |
eudract | LOC | 1 |
ethics committee of huashan hospital | ORG | 1 |
etheredge lm | PERSON | 1 |
erythema multiforme stevens johnson syndrome | DISEASE | 1 |
ernest ren ben brugts jasper j daemen joost mcfadden eugene | PERSON | 1 |
erin l gibson allison | PERSON | 1 |
fris | ORG | 1 |
fulminant hepatitis hepatotoxicity | DISEASE | 1 |
functioning disability | DISEASE | 1 |
furthermore ecg | ORG | 1 |
h1n1_09 | DISEASE | 1 |
gyeongsangbuk | GPE | 1 |
gyeonggi | ORG | 1 |
gurmeet chaturvedi pankaj | PERSON | 1 |
guillain barré | ORG | 1 |
guillain | DISEASE | 1 |
group a and group b | ORG | 1 |
group | ORG | 1 |
grounded theory method gtm | ORG | 1 |
griffiths gopnik | PERSON | 1 |
greve thomsen | PERSON | 1 |
grasselli | PERSON | 1 |
graphical | ORG | 1 |
graphpad prism graphpad prism | ORG | 1 |
granulomatosis | DISEASE | 1 |
gram | PERSON | 1 |
governance | PERSON | 1 |
gordon | ORG | 1 |
gopnik | PERSON | 1 |
h5n1 | TAXON | 1 |
hcsc | ORG | 1 |
healthcare workers | CHEMICAL | 1 |
hackman scholars program | PERSON | 1 |
happenings a | CHEMICAL | 1 |
hamilton david w steel | PERSON | 1 |
hamazaki 2013 | PERSON | 1 |
hamazaki | CHEMICAL | 1 |
hajj pilgrims | PERSON | 1 |
hajj | PERSON | 1 |
hague | DISEASE | 1 |
haddy loubna hansen | PERSON | 1 |
hacid | CHEMICAL | 1 |
hif | ORG | 1 |
hta authorship | ORG | 1 |
hta | ORG | 1 |
hmc | ORG | 1 |
hivinfected | ORG | 1 |
hiv viral | TAXON | 1 |
hiv disease | DISEASE | 1 |
hiv aids | DISEASE | 1 |
hitech | ORG | 1 |
goodman | ORG | 1 |
good clinical practice gcp guidelines | ORG | 1 |
good clinical practice gcp | ORG | 1 |
gabriel cohen | PERSON | 1 |
genvcollected | ORG | 1 |
genv s solutions hub | ORG | 1 |
genv s operational advisory committee | ORG | 1 |
genv trials oversight committee | ORG | 1 |
garry russ | PERSON | 1 |
garry b120 | PERSON | 1 |
garrison 2009 | ORG | 1 |
gamez anne | CHEMICAL | 1 |
gaborit | CHEMICAL | 1 |
gender idelalisib | PERSON | 1 |
gp 55 | ORG | 1 |
golg | ORG | 1 |
gmp | CHEMICAL | 1 |
gm instruments | ORG | 1 |
glucocovid | ORG | 1 |
gee | CHEMICAL | 1 |
gdpr directive | ORG | 1 |
gc rieber foundations | ORG | 1 |
gender | PERSON | 1 |
general data protection regulation gdpr | ORG | 1 |
good clinical practice | ORG | 1 |
gibson michael k yang peter | PERSON | 1 |
globally | ORG | 1 |
glasgow russell | PERSON | 1 |
glasgow | GPE | 1 |
glaser glaser | PERSON | 1 |
glaser | PERSON | 1 |
gilead sciences sab biotherapeutics | ORG | 1 |
gilead sciences inc | ORG | 1 |
gilead | ORG | 1 |
gibson | PERSON | 1 |
generation victoria figshare | PERSON | 1 |
ghazawi feras | ORG | 1 |
ghazal | CHEMICAL | 1 |
germany 63 | GPE | 1 |
george et al 2018 | PERSON | 1 |
george washington university | ORG | 1 |
geographical | PERSON | 1 |
gentofte hospital | ORG | 1 |
generation_victoria 35822 | CHEMICAL | 1 |
elie dit cosaque | PERSON | 1 |
elie a | PERSON | 1 |
clin pharmacol ther doi | PERSON | 1 |
costall 1993 | ORG | 1 |
dht | CHEMICAL | 1 |
dha | CHEMICAL | 1 |
dc | GPE | 1 |
d4 mean | ORG | 1 |
d11 mean | ORG | 1 |
d1 d11 | PERSON | 1 |
d title anticoagulation | CHEMICAL | 1 |
d dimers 1 2 mg l | CHEMICAL | 1 |
d group a | ORG | 1 |
d experimental | ORG | 1 |
d day dfid department for international development dsmb data and safety monitoring board | ORG | 1 |
cyclosporin a | CHEMICAL | 1 |
cyclosporin | CHEMICAL | 1 |
crown | ORG | 1 |
crohn disease | DISEASE | 1 |
crohn | PERSON | 1 |
crit care | ORG | 1 |
covid 19associated penumonia covac | DISEASE | 1 |
covid 19 compassionate use of remdesivir for patients with | ORG | 1 |
diamond | ORG | 1 |
djc | ORG | 1 |
dkk 2 2 million | ORG | 1 |
dana michele | PERSON | 1 |
data safety monitoring board | ORG | 1 |
data repository | ORG | 1 |
data management plan | ORG | 1 |
data exploring | ORG | 1 |
daphne lenz | PERSON | 1 |
daniel ratitch | PERSON | 1 |
dang et al | PERSON | 1 |
dang pham | PERSON | 1 |
dam | CHEMICAL | 1 |
dmc efficacy | ORG | 1 |
dale gordon | PERSON | 1 |
dale b1 | PERSON | 1 |
dale | PERSON | 1 |
dabus guilherme | PERSON | 1 |
dsmb chair | PERSON | 1 |
ds | ORG | 1 |
dress azithromycin | CHEMICAL | 1 |
dr | DISEASE | 1 |
council of advisors on science and technology pcast report | ORG | 1 |
cosgrave david | PERSON | 1 |
elephas | GPE | 1 |
correction larotrectinib | PERSON | 1 |
confirmatory adaptive designs | ORG | 1 |
conclusions children | PERSON | 1 |
compassionate use of remdesivir | PERSON | 1 |
comorbidities | PERSON | 1 |
collaborative group | ORG | 1 |
cognitive flexibility | DISEASE | 1 |
cognitive decline | DISEASE | 1 |
cochrane handbook | PERSON | 1 |
cochrane central register of controlled trials | ORG | 1 |
cochrane central register of | ORG | 1 |
cochrane covid 19 | ORG | 1 |
cochrane 12 keus | ORG | 1 |
cochrane | PERSON | 1 |
clustered | DISEASE | 1 |
cluster | PERSON | 1 |
cloyd | DISEASE | 1 |
clorocovid 19 study a | ORG | 1 |
clinical trials facilitation and coordination group | ORG | 1 |
clinical research development unit | ORG | 1 |
conflicts | ORG | 1 |
connecticut | GPE | 1 |
consensi | PERSON | 1 |
core minimal | PERSON | 1 |
correcting | PERSON | 1 |
corporate social networking sites modes of use and appropriation through co evolution australasian conference on information systems | ORG | 1 |
coronavirus disease covid | DISEASE | 1 |
coronavirus sars cov | DISEASE | 1 |
coronavirus pneumonia | DISEASE | 1 |
coronavirus infected pneumonia | DISEASE | 1 |
cornell scale for depression in dementia development | ORG | 1 |
core outcome sets | PERSON | 1 |
core | ORG | 1 |
consensi for hypertension and osteoarthritis bioequivalence | ORG | 1 |
coquery | DISEASE | 1 |
coordinating | ORG | 1 |
convalescent | DISEASE | 1 |
contradicted | CHEMICAL | 1 |
constraints | ORG | 1 |
consiglio dei ministri dipartimento della protezione | CHEMICAL | 1 |
conservation home | ORG | 1 |
conservation bushmeat | ORG | 1 |
data safety monitoring committees | ORG | 1 |
data analysis | ORG | 1 |
data and safety monitoring board | ORG | 1 |
dataset topics mds | PERSON | 1 |
ecmo | ORG | 1 |
ec patient | ORG | 1 |
d³ | CHEMICAL | 1 |
dyspnea pneumonia oedema eosinophilia leukopenia neutropenia elevated | ORG | 1 |
dynamic | ORG | 1 |
dwayne b64 | PERSON | 1 |
dutz | DISEASE | 1 |
duso | DISEASE | 1 |
dupilumab | DISEASE | 1 |
duffett mark choong karen | PERSON | 1 |
due | ORG | 1 |
drugs world health organization plague | ORG | 1 |
drugs fda fda | ORG | 1 |
dreyfuss didier | PERSON | 1 |
drawing | GPE | 1 |
drl | ORG | 1 |
douglas willson | PERSON | 1 |
dot | ORG | 1 |
don | PERSON | 1 |
eeg | ORG | 1 |
emr | ORG | 1 |
encyclopedia | DISEASE | 1 |
eddy j chen | PERSON | 1 |
elbanna | LOC | 1 |
el tor | GPE | 1 |
el | CHEMICAL | 1 |
einstellung | GPE | 1 |
efpraxia d pouloudi nancy giaglis george m wareham jonathan title appropriating information | CHEMICAL | 1 |
efficacy and safety trial | ORG | 1 |
effectiveness of methotrexate | ORG | 1 |
effectiveness of | ORG | 1 |
eastern european diabetes expert group | ORG | 1 |
eq 5d | ORG | 1 |
east respiratory syndrome mers | DISEASE | 1 |
east asia | LOC | 1 |
early transmission dynamics | ORG | 1 |
ear nose | PERSON | 1 |
ery | CHEMICAL | 1 |
eravscorona | CHEMICAL | 1 |
equity systematic | ORG | 1 |
equity | DISEASE | 1 |
domestic dogs | TAXON | 1 |
domenica | CHEMICAL | 1 |
dolutegravir plus two different prodrugs of tenofovir to treat hiv | ORG | 1 |
deaths | DISEASE | 1 |
dell | ORG | 1 |
delays | DISEASE | 1 |
dedhia | CHEMICAL | 1 |
decreased appetite vomiting taste disorders | DISEASE | 1 |
declaration of helsinki ethical principles for medical research | ORG | 1 |
decades | DISEASE | 1 |
deborah j | PERSON | 1 |
deborah howel denise | PERSON | 1 |
death | DISEASE | 1 |
dementia pain | DISEASE | 1 |
dean natalie | PERSON | 1 |
desanctis poole desanctis | ORG | 1 |
davison | PERSON | 1 |
david xia | PERSON | 1 |
david tavernier | PERSON | 1 |
david mocco | PERSON | 1 |
david chen yaolong | PERSON | 1 |
dataverse | CHEMICAL | 1 |
dementia csdd | DISEASE | 1 |
dementia rud | ORG | 1 |
dolutegravir | CHEMICAL | 1 |
dickersin | PERSON | 1 |
doargajudhur | PERSON | 1 |
dizziness skin | PERSON | 1 |
disruption of | ORG | 1 |
disaster | PERSON | 1 |
disagreements | CHEMICAL | 1 |
dimitris meerpohl joerg | PERSON | 1 |
differential | ORG | 1 |
dickersin k | CHEMICAL | 1 |
diarrhoea vomiting emotional | ORG | 1 |
dementias triad | CHEMICAL | 1 |
diarrhoea vomiting | DISEASE | 1 |
diagnosis | GPE | 1 |
diabetic | DISEASE | 1 |
dipaola joshua d yindee | PERSON | 1 |
deák bauer | PERSON | 1 |
developmental | ORG | 1 |
desmarest 1822 | CHEMICAL | 1 |
dependent happenings a recent methodological review interdependence | ORG | 1 |
reducing burden delay | PERSON | 1 |
anginal pain | DISEASE | 1 |
reich 9 | PERSON | 1 |
molecular cancer | DISEASE | 1 |
mØdicale ethics | ORG | 1 |
myocardial infarction | DISEASE | 1 |
myeloid malignancies | DISEASE | 1 |
myeloid leukemias | PERSON | 1 |
myeloid leukemia | DISEASE | 1 |
mycophenolic acid | CHEMICAL | 1 |
myasthenia gravis | DISEASE | 1 |
murine gene deletion | TAXON | 1 |
murine coronavirus mhv | TAXON | 1 |
murine coronavirus | TAXON | 1 |
murine | TAXON | 1 |
multiple sclerosis | DISEASE | 1 |
multiple diseases | DISEASE | 1 |
multiorgan failure | DISEASE | 1 |
multicentre trial potential | ORG | 1 |
mucocutaneous | DISEASE | 1 |
moxifloxacin | CHEMICAL | 1 |
movement fatigue | DISEASE | 1 |
mount robust | LOC | 1 |
n8acd6hj | GPE | 1 |
ncov lung injury | DISEASE | 1 |
nan doi | PERSON | 1 |
neuropathy | DISEASE | 1 |
obstruction | DISEASE | 1 |
obsessive | DISEASE | 1 |
nucleotide | CHEMICAL | 1 |
noone | CHEMICAL | 1 |
nonhuman primates chimpanzees | TAXON | 1 |
nlm nih | ORG | 1 |
nitrogen | CHEMICAL | 1 |
nitazoxanide | CHEMICAL | 1 |
neuromuscular blockade | DISEASE | 1 |
nasal airflow impairment | DISEASE | 1 |
neoplastic disorders | DISEASE | 1 |
ncbi | CHEMICAL | 1 |
nasopharyngitis bronchitis cough | DISEASE | 1 |
nasopharyngeal carcinoma | DISEASE | 1 |
nasopharyngeal cancer | DISEASE | 1 |
nasal dryness irritation | DISEASE | 1 |
nasal block | DISEASE | 1 |
nasal airway obstruction | DISEASE | 1 |
monkeys | TAXON | 1 |
midazolam ddi | CHEMICAL | 1 |
leukemia | DISEASE | 1 |
methyl bis beta chloroethyl amine hydrochloride | CHEMICAL | 1 |
lupus nephritis chloroquine | DISEASE | 1 |
lupus erythematosus sle | DISEASE | 1 |
lungemedicin | CHEMICAL | 1 |
lung infections pneumonia | DISEASE | 1 |
lung disease | DISEASE | 1 |
lung damage | DISEASE | 1 |
lung caner | DISEASE | 1 |
lung and kidney qi deficiency | DISEASE | 1 |
lung adenocarcinoma | DISEASE | 1 |
lopinavir ritonavir versus umifenovir | PERSON | 1 |
lopinavir ritonavir n 1 596 | CHEMICAL | 1 |
lopinavir ritonavir n | CHEMICAL | 1 |
lopinavir ritonavir covid | CHEMICAL | 1 |
lopinavir 40 5 | CHEMICAL | 1 |
liver metastasis | DISEASE | 1 |
liver kidney function | DISEASE | 1 |
liver diseases | DISEASE | 1 |
lipoic acid | CHEMICAL | 1 |
lincomycin hcl | CHEMICAL | 1 |